Germany’s Merck KGaA has signed a collaboration with Tencent to develop digital healthcare services in China. Darmstadt-based Merck’s strategic tie-up with the China-based multinational tech ...

Merck KGaA has gone all-in on pimicotinib, paying Abbisko Therapeutics $85 million to secure the global license to the drug. The German pharma originally paid $70 million for the greater China ...

CEOs from large pharma companies AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GSK, Merck KGaA, Pfizer and Sanofi ... its biggest single investment in China to date, roughly 1 billion ...

Germany’s Merck KGaA is paying Chinese biotech Abbisko Therapeutics ... to the drug – called pimicotinib (ABSK021) – in China, Hong Kong, Macau, and Taiwan, with an option on rights for ...

FRANKFURT, April 9 (Xinhua) -- The benchmark DAX index in Germany on Wednesday dropped by 3 percent as market turmoil triggered by U.S. tariff policies lingers on. The DAX index closed at 19,670.88 ...

In November 2021, Biotecnica has recently introduced a new range of low endotoxin EndoLow peptones, which offer the advantage of not requiring ultrafiltration. The EndoLow Peptones provide a reliable ...

The semiconductor, electronics, and pharmaceutical industries play a vital role in the global high-purity sulfuric acid market, propelling it into an important steep rise. Given the rapid growth of ...

Pia Piquero, a 24-year-old journalist from Cebu Daily News Digital, has made history by winning first place in the online ...

In China, policymakers continued to stimulate ... company issued a modest outlook for full-year profit growth. Merck KGaA (OTCPK:MKGAF)(OTCPK:MKKGY) (Health Care, Pharmaceuticals) fell after ...

Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated the Global Xylitol in Personal Care and Cosmetics Market size at USD 158.11 million in 2023.

German life sciences and pharma company Merck KGaA (MRK: DE) today revealed it has exercised its option with China’s Abbisko Therapeutics (HKEX: 02256) for commercialization of pimicotinib in the US ...